4
Changes in Ownership
Cardiff Oncology, Inc. Filed Acc 0001104659-16-162330
Chief Scientific Officer bought 5,000 shares at $2.08 ($10,375)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Erlander Mark Chief Scientific Officer | 2016-12-14 | Purchase | +5,000 | $2.08 | $10,375 | 5,000 | D: show line 1 in the form |
| Open-market purchases · 5,000 sh · avg $2.08 · $10,375 | |||||||
Loading xslF345X03/a4.xml…